It remains unclear whether any modified SRT for relapsed PCa in patients without lymph node metastasis is superior to standard SRT as analyzed here, except for the addition of hormonal treatment for pre-SRT PSA values >0.7 ng/mL. Here, KLK3 is linked to metastatic malignant neoplasm in the lymph nodes.